RA Capital Nexus Fund IV, Director of Hemab Therapeutics Holdings COAG, has filed 6 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $52.2M. The latest trade was on 05/06.

RI

RI

RA Capital Nexus Fund IV

Director

Company

Hemab Therapeutics Holdings COAG

First filing

26/05/06

Trades

15 trades

Buys / sales

6 / 0

12-month net buying

$52.2M

Last trade

05/06

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Hemab Therapeutics HoldingsCOAG	Open-market buy	05/04–05/06	05/06	2,840,429 sh6 trades	$18.39avg.	$52,222,945.65	+81.8%